适体市场规模、份额、成长分析、按类型、应用、技术、最终用户、地区 - 产业预测，2025 年至 2032 年

适体市场规模预计在 2023 年达到 29.1 亿美元，并将从 2024 年的 36.3 亿美元增长到 2032 年的 210.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 24.6%。

由于慢性病盛行率的上升和标靶治疗的日益普及，全球适体市场预计将显着增长。对早期诊断解决方案的需求，加上对创新诊断技术不断增加的投资，可能会进一步推动该市场向前发展。此外，试管内选择（SELEX）技术的进步有望增加适体开发的机会。医学研究和开发的激增，加上人们对基因治疗的兴趣日益浓厚以及对适体益处的认识不断提高，为市场强劲扩张奠定了基础。然而，半衰期短、替代品可用性、可接受性有限以及法律规范严格等挑战可能会阻碍其发展。特别是美国和加拿大等新兴前沿地区已成为适体供应商的有前景的市场。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

适体市场规模（按类型）

• 市场概览
• DNA适体
• RNA适体
• XNA适体
• 胜肽适体
• 适体-药物偶联物（ApDC）

适体市场规模：按应用

• 市场概览
• 诊断
  • 生物标记检测
  • 病原体检测
  • 显影剂
  • 伴同性诊断
• 治疗
  • 肿瘤学
  • 心血管疾病
  • 感染疾病
  • 眼科
  • 发炎与自体免疫疾病
• 研究与开发
  • 分子探针
  • 目标检验
  • 蛋白质相互作用研究
• 生物感测器
  • 环境监测
  • 食品安全
  • 生物防御应用
• 药物输送系统
  • 定向投放
  • 控释製剂

适体市场规模：依技术分类

• 市场概览
• 赛莱克斯
  • 常规 SELEX
  • 细胞SELEX
  • 毛细管电泳SELEX
  • 微流体SELEX
  • 高通量SELEX
• SELEX 后优化技术
  • 化学改性
  • 截断
  • 二聚化
  • 聚乙二醇

按最终用户分類的适体市场规模

• 市场概览
• 製药和生物技术公司
• 学术研究所
• 临床实验室
• 合约研究组织（CRO）
• 诊断实验室

适体市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Aptamer Group（UK）
• Aptadel Therapeutics（USA）
• SomaLogic Operating Co., Inc.（USA）
• Base Pair Biotechnologies（USA）
• Vivonics, Inc.（USA）
• Aptagen, LLC（USA）
• Aptus Biotech（Spain）
• TriLink BioTechnologies（USA）
• AM Biotechnologies, LLC（USA）
• Maravai LifeSciences（USA）

结论和建议

Aptamers Market size was valued at USD 2.91 billion in 2023 and is poised to grow from USD 3.63 billion in 2024 to USD 21.06 billion by 2032, growing at a CAGR of 24.6% during the forecast period (2025-2032).

The global market for aptamers is poised for significant growth, driven by the rising prevalence of chronic diseases and the increasing adoption of targeted therapeutics. The demand for early diagnostic solutions, backed by heightened investments in innovative diagnostic technologies, will further propel this market forward. Additionally, advancements in SELEX technology are expected to enhance aptamer development opportunities. The surge in medical research and development, coupled with a growing focus on genetic therapies and heightened awareness of aptamer benefits, positions the market for robust expansion. However, challenges such as short half-life, availability of alternatives, limited acceptance, and stringent regulatory frameworks may hinder growth. Notably, developed regions like the United States and Canada are emerging as promising markets for aptamer providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Aptamers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Aptamers Market Segments Analysis

Global Aptamers Market is segmented by Type, Application, Technology, End-User and region. Based on Type, the market is segmented into DNA Aptamers, RNA Aptamers, XNA Aptamers, Peptide Aptamers and Aptamer-drug conjugates (ApDCs). Based on Application, the market is segmented into Diagnostics, Therapeutics, Research & Development, Biosensors and Drug Delivery Systems. Based on Technology, the market is segmented into SELEX and Post-SELEX Optimization Techniques. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Laboratories,Contract Research Organizations(CROs) and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Aptamers Market

The aptamers market is being propelled by the increasing investments in the advancement of drug delivery technologies, which have facilitated the emergence of targeted therapeutics. These therapeutics are gaining widespread acceptance globally due to their ability to minimize unexpected side effects, offering a safer alternative to traditional treatments. As a result, the utilization of aptamers in the development of these specialized drugs is contributing significantly to the growth of the market. With the rising demand for targeted therapies, the role of aptamers as key components in innovative drug development is becoming more prominent, driving further evolution in this sector.

Restraints in the Aptamers Market

The Aptamers market faces a significant constraint due to the notably brief half-life of aptamers, which typically spans just minutes to hours. This limited duration poses substantial challenges in identifying viable practical applications for these molecules. Efforts to manage the short half-life while preserving the unique characteristics of aptamers without degradation present a formidable obstacle. Consequently, these difficulties are anticipated to hinder the growth and demand for aptamers in the market in the coming years, as researchers and manufacturers struggle to optimize their stability and functionality for effective use in various applications.

Market Trends of the Aptamers Market

The global aptamer market is witnessing a significant trend towards the incorporation of chemical modifications to enhance aptamer stability and functionality. As researchers and aptamer providers increasingly focus on innovations such as PEGylation and locked nucleic acid (LNA) modifications, the market is expected to expand due to improvements in pharmacokinetics, target binding, and reduced degradation in biological systems. These advancements will not only broaden the application scope of aptamers in therapeutics and diagnostics but also cater to the growing demand for more efficient and durable biotherapeutics, positioning modified aptamers as a pivotal element in the biotechnology landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Aptamers Market Size by Type & CAGR (2025-2032)

• Market Overview
• DNA Aptamers
• RNA Aptamers
• XNA Aptamers
• Peptide Aptamers
• Aptamer-drug conjugates (ApDCs)

Global Aptamers Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
  • Biomarker Detection
  • Pathogen Detection
  • Imaging Agents
  • Companion Diagnostics
• Therapeutics
  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Ophthalmology
  • Inflammatory & Autoimmune Diseases
• Research & Development
  • Molecular Probes
  • Target Validation
  • Protein Interaction Studies
• Biosensors
  • Environmental Monitoring
  • Food Safety
  • Biodefense Applications
• Drug Delivery Systems
  • Targeted Delivery
  • Controlled Release Formulations

Global Aptamers Market Size by Technology & CAGR (2025-2032)

• Market Overview
• SELEX
  • Conventional SELEX
  • Cell-SELEX
  • Capillary Electrophoresis SELEX
  • Microfluidic SELEX
  • High-throughput SELEX
• Post-SELEX Optimization Techniques
  • Chemical Modifications
  • Truncation
  • Dimerization
  • PEGylation

Global Aptamers Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Clinical Laboratories
• Contract Research Organizations (CROs)
• Diagnostic Laboratories

Global Aptamers Market Size & CAGR (2025-2032)

• North America (Type, Application, Technology, End-User)
  • US
  • Canada
• Europe (Type, Application, Technology, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Technology, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Technology, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Technology, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Aptamer Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptadel Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SomaLogic Operating Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Base Pair Biotechnologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivonics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptagen, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptus Biotech (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriLink BioTechnologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AM Biotechnologies, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maravai LifeSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations